Table 2.
Domain | Residuea | PTM | Modifying enzyme | Effect on necroptosis | Proposed mechanism | Ortholog studied | Cell modelb | Mouse model | Recombinant protein | Reference | |
---|---|---|---|---|---|---|---|---|---|---|---|
Human | Mouse | ||||||||||
Kinase | T182 | T187 | Phosphorylation | Auto | Both ↑ and ↓, net effect unclear | Promotes RIPK3 kinase activity; but also recruits PELI1 which targets RIPK3 for proteasomal degradation | Human | HT29, 293T | No | Yes | [164] |
Kinase | S199 | S204 | Phosphorylation | Auto | ↑ Promotes necroptosis | Promotes RIPK3 kinase activity | Human, mouse | MEF, Jurkat, HT29 | No | Yes | [87] |
Kinase | S227 | T231/S232 | Phosphorylation | Auto | ↑ Promotes necroptosis | Promotes interaction with MLKL | Mouse, human | MEF, Jurkat, HT29 | No | Yes | [28, 87] |
S227 | T231/S232 | CK1α, CK1δ, and CK1ε | Human | HeLa | No | Yes | [181] | ||||
S227 | T231/S232 | Dephosphorylation | Ppm1b | ↓ Restrict necroptosis | Antagonize essential phosphorylation | Human, mouse | 293T, L929, HeLa | Yes | Yes | [183] | |
Kinase | K5 | K5 | Deubiquitination | A20 | ↓ Inhibits complex II formation and cell death | A20 deubiquitinate K63-linked ubiquitin chain of RIPK3 at K5, which is required for necrosome formation | Mouse | T cell, MEF | No | No | [184] |
Kinase | K55 | K56 | K48-linked ubiquitination | CHIP | ↓ Attenuates necroptosis | Targets RIPK3 for lysosomal degradation | Mouse, human | MEF, L929, HT29 | Yes | No | [156] |
Kinase | K89 | – | K48-linked ubiquitination | CHIP | – | – | – | – | – | – | [156] |
Intermediate | K363 | – | K48-linked ubiquitination | CHIP | ↓ Attenuates necroptosis | Targets RIPK3 for lysosomal degradation | Mouse, human | MEF, L929, HT29 | Yes | No | [156] |
– | K48-linked ubiquitination | PELI1 | ↓ Attenuates necroptosis | Targets RIPK3 for proteasomal degradation | Mouse, human | MEF, HT29 | No | No | [164] | ||
Intermediate | K501 | – | K48-linked ubiquitination | CHIP | – | – | – | – | – | – | [156] |
Intermediate | D328 | D333 | Cleavage | Casp8 | ↓ Inhibits necroptosis | Protease cleavage | Human | HeLa, 293T | No | Yes | [36, 171] |
RHIM | N462 | Y453 | Cleavage | EspL | ↓ (Pathogen) inhibits necroptosis | Protease cleavage | Mouse | MDF, BMDM | Yes | Yes | [17] |
RHIM | T467 | Unknown | O-GlcNAc | OGT | ↓ Attenuates necroptosis | Steric hinderance prevent RHIM-mediated RIPK1-RIPK3 interaction | Human, mouse | 293T, L929, THP-1, BMDM | Yes | No | [185] |
aEquivalent residues in human and mouse orthologs are inferred by sequence homology. Bold indicates the ortholog residue with direct evidence of such post-translational modification.
bCell line abbreviations: HT29 human adenocarcinoma cells, 293T human embryonic kidney cell line HEK293T, MEF mouse embryonic fibroblasts, Jurkat human T lymphocyte Jurkat cells, HeLa human adenocarcinoma cells, L292 mouse fibrosarcoma cells, BMDM bone marrow-derived macrophages, THP-1 human monocyte-like cells.